Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO – Get Free Report) dropped 4.7% during trading on Thursday . The company traded as low as $0.37 and last traded at $0.40. Approximately 63,797 shares traded hands during trading, a decline of 96% from the average daily volume of 1,446,947 shares. The stock had previously closed at $0.42.
Klotho Neurosciences Stock Performance
The company has a 50-day moving average price of $0.45.
About Klotho Neurosciences
Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
Featured Stories
- Five stocks we like better than Klotho Neurosciences
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Invest in Small Cap Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Klotho Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klotho Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
